Date Name Title Filing Type Shares Traded Price Total Held
Feb 03, 2006
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 16,000 -- --
Feb 03, 2006
SVP, PreclinDevel & Biomol Sci
SVP, PreclinDevel & Biomol Sci Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 24,000 -- --
Feb 01, 2006
Director
Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 1,246 $12.00 1,836
Feb 01, 2006
Director
Director Form 4 Open market or private sale of non-derivative or derivative security 1,246 $15.24 590
Feb 01, 2006
Director
Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 2,071 $12.00 2,661
Feb 01, 2006
Director
Director Form 4 Open market or private sale of non-derivative or derivative security 2,071 $15.25 590
Feb 01, 2006
Director
Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 2,968 $12.00 3,558
Feb 01, 2006
Director
Director Form 4 Open market or private sale of non-derivative or derivative security 2,968 $15.30 590
Feb 01, 2006
Director
Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 1,465 $12.00 2,055
Feb 01, 2006
Director
Director Form 4 Open market or private sale of non-derivative or derivative security 1,465 $15.40 590

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.